Clinical Trial Update: Phase IV Bioseal Study in Brain Tumor Surgery [Phase 4]

View source ↗

Summary

Phase IV study evaluating Ethicon's Bioseal hemostatic sealant in meningioma brain tumor surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• Bioseal

Snippet

Sponsor: Ethicon, Inc. | Conditions: Hemostasis, Meningioma Surgery | Phase 4 | Status: COMPLETED | Results posted: 2018-02-26